dc.contributorMeléndez Rhenals, Sugeich del Mar
dc.contributorPáez Ardila, Hugo Alberto
dc.contributorPuentes Ariza, Gean Carlo (0000-0002-7001-1157)
dc.creatorPuentes Ariza, Gean Carlo
dc.date.accessioned2023-01-31T16:03:12Z
dc.date.accessioned2023-06-06T23:21:38Z
dc.date.available2023-01-31T16:03:12Z
dc.date.available2023-06-06T23:21:38Z
dc.date.created2023-01-31T16:03:12Z
dc.date.issued2023-01-30
dc.identifierhttps://repositorio.unal.edu.co/handle/unal/83215
dc.identifierUniversidad Nacional de Colombia
dc.identifierRepositorio Institucional Universidad Nacional de Colombia
dc.identifierhttps://repositorio.unal.edu.co/
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/6651247
dc.description.abstractIntroducción: La coinfección por tuberculosis es la principal causa de muerte en los pacientes con infección por VIH. No existen datos recientes con respecto a las características sociodemográficas y clínicas de los pacientes con coinfección por tuberculosis y VIH en Bogotá. Objetivos: Establecer la prevalencia de infección por VIH en pacientes con infección por tuberculosis pulmonar y extrapulmonar y describir sus características. Materiales y métodos: Estudio retrospectivo de corte transversal, en pacientes con diagnóstico de infección por tuberculosis y coinfección por VIH, atendidos en el Hospital Simón Bolívar de Bogotá entre 2019 y 2021. Resultados: Se incluyeron 54 pacientes, lo que representa el 52,3% de los pacientes con tuberculosis atendidos en el hospital en el periodo evaluado. La mediana de edad fue de 38 años (RIQ: 13 años). El 79,6% (43) fueron hombres. La mediana de conteo de CD4 fue de 59 células/µL (RIQ: 88 células/µL); 72,2% (39) tuvieron un conteo menor a 200 células/µL. El diagnóstico de infección por VIH de novo a partir de la sospecha de infección tuberculosa se encontró en el 35,2% (19). El 31,4% (11) de los pacientes con infección conocida por VIH recibía TARV. Se hizo diagnóstico de otra infección oportunista concomitante en 55,6% (30). El 51,9% (28) tuvieron tuberculosis pulmonar. La distribución de la localización de los casos de tuberculosis extrapulmonar fue meníngea (29,6%), seguida de compromiso miliar (12,9%), pleural (3,7%) y peritoneal (3,7%). Se hizo diagnóstico microbiológico de TB pulmonar o extrapulmonar en 35,2% (19). Se registró un 33,3% de mortalidad intrahospitalaria. En el análisis bivariado la mortalidad intrahospitalaria se asoció con el conteo de CD4 (p=0.048), el diagnóstico de VIH de novo (p = 0.036) y la presencia de TB meníngea (p=0.022). Conclusiones: La coinfección por TB en pacientes con infección por VIH se relaciona con un alto grado de inmunosupresión. En un alto porcentaje se llegó al diagnóstico de VIH de novo a partir de la sospecha de infección por tuberculosis, lo que resalta la importancia de la búsqueda activa de la coinfección. Nuestra población presenta TB de localización meníngea con mayor frecuencia, con importantes implicaciones clínicas y asociación con mortalidad intrahospitalaria. (Texto tomado de la fuente)
dc.description.abstractIntroduction: Tuberculosis coinfection is the main cause of death in patients with HIV infection. There are no recent data regarding the sociodemographic and clinical characteristics of patients with tuberculosis and HIV coinfection in Bogota. Objectives: To establish the prevalence of HIV infection in patients with pulmonary and extrapulmonary tuberculosis infection and describe its characteristics. Materials and methods: Retrospective cross-sectional study, in patients with diagnosis of tuberculosis infection and HIV coinfection, treated at the Simon Bolivar Hospital in Bogota between 2019 to 2021. Results: 54 patients were included, which represents 52.3% of the patients with tuberculosis treated at the hospital in the period evaluated. The median age was 38 years (IQR: 13 years). 79.6% (43) were men. The median CD4 count was 59 cells/µL (IQR: 88 cells/µL); 72.2% (39) had a count of less than 200 cells/µL. The diagnosis of new HIV infection based on the suspicion of tuberculosis infection was found in 35.2% (19). 31.4% (11) of the patients with known HIV infection were receiving ART. A diagnosis of another concomitant opportunistic infection was made in 55.6% (30). 51.9% (28) had pulmonary tuberculosis. The distribution of the location of the extrapulmonary tuberculosis cases was meningeal (29.6%), followed by miliary (12.9%), pleural (3.7%) and peritoneal (3.7%) involvement. A microbiological diagnosis of pulmonary or extrapulmonary TB was made in 35.2% (19). In-hospital mortality was 33.3%. In the bivariate analysis, in-hospital mortality was associated with CD4 count (p=0.048), new HIV diagnosis (p=0.036) and the presence of meningeal TB (p=0.022). Conclusions: TB coinfection in patients with HIV infection is related to a high degree of immunosuppression. A high percentage of patients were diagnosed with new HIV based on the suspicion of tuberculosis infection, which highlights the importance of the active search for coinfection. Our population presents meningeal TB more frequently, with important clinical implications and association with in-hospital mortality.
dc.languagespa
dc.publisherUniversidad Nacional de Colombia
dc.publisherBogotá - Medicina - Especialidad en Medicina Interna
dc.publisherFacultad de Medicina
dc.publisherBogotá, Colombia
dc.publisherUniversidad Nacional de Colombia - Sede Bogotá
dc.relationMurray CJL, Ortblad KF, Guinovart C, Lim SS, Wolock TM, Roberts DA, et al. Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013. The Lancet. 2014;384(9947):1005–70.
dc.relationDeeks SG, Overbaugh J, Phillips A, Buchbinder S. HIV infection. Nat Rev Dis Primers. 2015;1(October):15035
dc.relationUNAIDS. IN DANGER: UNAIDS Global AIDS Update 2022. Geneva: Joint United Nations Programme on HIV/AIDS. 2022.
dc.relationPawlowski A, Jansson M, Sköld M, Rottenberg ME, Källenius G. Tuberculosis and HIV co-infection. PLoS Pathog. 2012;8(2):1002464.
dc.relationÚriz Ayestarán J, Repáraz J, Castiello J, Sola J. Tuberculosis en pacientes infectados por el VIH. An Sist Sanit Navar. 2007;30(SUPPL. 2):131–42.
dc.relationWorld Health Organization (WHO). Global tuberculosis report 2022 [Internet]. Geneva; 2022. Available from: http://apps.who.int/bookorders
dc.relationLetang E, Ellis J, Naidoo K, Casas EC, Sánchez P, Hassan-Moosa R, et al. Tuberculosis-HIV Co-Infection: Progress and Challenges After Two Decades of Global Antiretroviral Treatment Roll-Out. Arch Bronconeumol. 2020;56(7):446–54
dc.relationGray JM, Cohn DL. Tuberculosis and HIV coinfection. Semin Respir Crit Care Med. 2013;34(1):32–43.
dc.relationEdge CL, King EJ, Dolan K, McKee M. Prisoners co-infected with tuberculosis and HIV: A systematic review: A. J Int AIDS Soc. 2016;19(1):20960.
dc.relationWorld Health Organization (WHO). Global tuberculosis report 2021 [Internet]. Geneva; 2021. Available from: https://www.who.int/publications/i/item/9789240037021
dc.relationMesfin YM, Hailemariam D, Biadglign S, Kibret KT. Association between HIV/AIDS and multi-drug resistance tuberculosis: a systematic review and meta-analysis. PLoS One. 2014 ene 8;9(1):e82235
dc.relationFadul Perez S. Protocolo de Vigilancia de Tuberculosis. Instituto Nacional de Salud [Internet]. 2022;1–33. Available from: https://doi.org/10.33610/infoeventos
dc.relationFaria NR, Rambaut A, Suchard MA, Baele G, Bedford T, Ward MJ, et al. The early spread and epidemic ignition of HIV-1 in human populations. Science (1979). 2014 oct 3;346(6205):56–61
dc.relationGottlieb MS, Schroff R, Schanker HM, Weisman JD, Fan PT, Wolf RA, et al. Pneumocystis carinii Pneumonia and Mucosal Candidiasis in Previously Healthy Homosexual Men . New England Journal of Medicine. 1981 dic 10;305(24):1425–31.
dc.relationBarré-Sinoussi F, Chermann JC, Rey F, Nugeyre MT, Chamaret S, Gruest J, et al. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science (1979). 1983;220(4599):868–71
dc.relationCuellar Espitia NC. Protocolo de vigilancia en salud pública VIH / sida. Instituto Nacional de Salud [Internet]. 2020;1–19. Available from: https://www.ins.gov.co/buscador-eventos/Lineamientos/PRO VIH sida_.pdf
dc.relationFondo Colombiano de Enfermedades de Alto Costo C de AC (CAC). Situación del VIH y sida en Colombia 2021. Bogotá D.C.; 2021
dc.relationUNAIDS. Orientaciones terminológicas de ONUSIDA [Internet]. 2015. Available from: https://www.unaids.org/es/resources/documents/2015/2015_terminology_guidelines
dc.relationBell LCK, Noursadeghi M. Pathogenesis of HIV-1 and mycobacterium tuberculosis co-infection. Vol. 16, Nature Reviews Microbiology. Nature Publishing Group; 2018. p. 80–90
dc.relationPai M, Behr MA, Dowdy D, Dheda K, Divangahi M, Boehme CC, et al. Tuberculosis. Nat Rev Dis Primers. 2016;2:20960
dc.relationRockwood N, Wilkinson RJ. Understanding and intervening in HIV-associated tuberculosis. Clinical Medicine, Journal of the Royal College of Physicians of London. 2015;15(6):s43–9.
dc.relationUnited Nations. The Millennium Development Goals Report [Internet]. New York; 2008. Available from: https://www.un.org/millenniumgoals/2008highlevel/pdf/newsroom/mdg%20reports/MDG_Report_2008_ENGLISH.pdf
dc.relationHolmberg V, Soini H, Kivelä P, Ollgren J, Ristola M. Epidemiology and outcome of HIV patients in Finland co-infected with tuberculosis 1998-2015. BMC Infect Dis. 2019;19(1):1–8.
dc.relationShivakoti R, Sharma D, Mamoon G, Pham K. Association of HIV infection with extrapulmonary tuberculosis: a systematic review. Vol. 45, Infection. Urban und Vogel GmbH; 2017. p. 11–21.
dc.relationBruchfeld J, Correia-Neves M, Kallenius G. Tuberculosis and HIV coinfection. Cold Spring Harb Perspect Med. 2015 jul 1;5(7):a017871.
dc.relationHouben RMGJ, Glynn JR, Mallard K, Sichali L, Malema S, Fine PEM, et al. Human immunodeficiency virus increases the risk of tuberculosis due to recent re-infection in individuals with latent infection. International Journal of Tuberculosis and Lung Disease. 2010;14(7):909–15.
dc.relationGeldmacher C, Ngwenyama N, Schuetz A, Petrovas C, Reither K, Heeregrave EJ, et al. Preferential infection and depletion of Mycobacterium tuberculosis-specific CD4 T cells after HIV-1 infection. J Exp Med. 2010 dic 20;207(13):2869–81
dc.relationKawatsu L, Uchimura K, Kaneko N, Imahashi M. Epidemiology of coinfection with tuberculosis and HIV in Japan, 2012-2020. Western Pac Surveill Response J. 2022 ene 1;13(1):1–8.
dc.relationZohar M, Moshe L, Daniel C, Noa C, Itamar G. HIV prevalence in the Israeli tuberculosis cohort, 1999-2011 Disease epidemiology - Infectious. BMC Public Health. 2014;14(1):1–5.
dc.relationWorld Health Organization (WHO). Global tuberculosis report 2020. [Internet]. Global tuberculosis report 2020. Geneva; 2020. Available from: https://www.who.int/publications/i/item/9789240013131
dc.relationSanhueza-Sanzana C, Kerr L, Kendall C. Mortality from AIDS and tuberculosis-HIV coinfection in the Chilean AIDS Cohort of 2000-2017. Cad Saude Publica. 2021;37(6):e00212920
dc.relationTancredi MV, Sakabe S, Waldman EA. Mortality and survival of tuberculosis coinfected patients living with AIDS in São Paulo, Brazil: a 12-year cohort study. BMC Infect Dis. 2022 dic 1;22(1):1–13.
dc.relationTeixeira De Siqueira-Filha N, Militao De Albuquerque MDF, Cunha Rodrigues L, Legood R, Costa Santos A. Economic burden of HIV and TB/HIV coinfection in a middle-income country: A costing analysis alongside a pragmatic clinical trial in Brazil. Sex Transm Infect. 2018;94(6):463–9
dc.relationMurcia MI, León CI, de La Hoz F, Saravia J. Asociación Micobacterias-VIH/SIDA en Pacientes Atendidos en un Hospital Universitario en Bogotá, Colombia. Rev salud publica. 2007;9(1):97–105.
dc.relationGarcía I, Merchán A, Enrique Chaparro P, Edith López L. Panorama de la coinfección tuberculosis/VIH en Bogotá. Biomédica. 2004;24:132–9
dc.relationCortés JA, Al ET, Hidalgo P, Lucía D, Sánchez R, Adolfo G, et al. Tuberculosis en pacientes con infección por VIH en el Hospital Universitario San Ignacio, 2002-2006. Infectio. 2007;11(1):16–22
dc.relationPeñuela-Epalza M, Vásquez-Beltrán M, De K, Rosa-Barraza L, Hernández-Tapia H, Collazos-Daza J, et al. Factores asociados a la coinfección VIH/SIDA-tuberculosis. Revista Científica Salud Uninorte. 2006;22(1):1–11
dc.relationPlata-Casas L, Gutiérrez-Lesmes O, Herrán-Falla O. Infección concomitante por tuberculosis y el virus de la inmunodeficiencia humana: situación epidemiológica en el departamento del Meta, 2010-2015. Biomedica. 2018;38:68–79
dc.relationMontúfar Andrade FE, Villa Franco P, Montúfar Pantoja MC, Zuleta Tobón JJ, Pérez Jaramillo LE, Monsalve Valencia MA, et al. Coinfección por virus de inmunodeficiencia humana y micobacterias en un hospital universitario de alta complejidad en Colombia. Infectio. 2016 jul 1;20(3):158–64
dc.relationWorld Health Organization (WHO). Guidelines for intensified tuberculosis case-finding and isoniazid preventive therapy for people living with HIV in resource-constrained settings. 2015;1–27. Available from: https://apps.who.int/iris/bitstream/handle/10665/44472/9789241500708_eng.pdf?sequence=1
dc.relationJones BE, Young SMM, Antoniskis D, Davidson PT, Kramer F, Barnes PF. Relationship of the manifestations of tuberculosis to CD4 cell counts in patients with human immunodeficiency virus infection. American Review of Respiratory Disease. 1993;148(5):1292–7
dc.relationKeiper MD, Beumont M, Elshami A, Langlotz CP, Miller WT. CD4 T lymphocyte count and the radiographic presentation of pulmonary tuberculosis: A study of the relationship between these factors in patients with human immunodeficiency virus infection. Chest. 1995;107(1):74–80
dc.relationWorld Health Organization (WHO). Policy Statement: Automated real-time Nucleic Acid Amplification Technology for Rapid and Simultaneous Detection of Tuberculosis and Rifampicin Resistance: Xpert MTB/RIF System [Internet]. World Health Organization. Geneva; 2011. Available from: http://www.stoptb.org/wg/gli/assets/documents/Xpert Implementation Document.pdf
dc.relationColombia. Ministerio de Salud y Protección Social. Lineamiento técnico operativo del Programa Nacional de Tuberculosis. Dirección de Promoción y Prevención. Subdirección de Enfermedades Transmisibles. Bogotá DC; 2020
dc.relationSharma SK, Mohan A, Sharma A. Miliary tuberculosis: A new look at an old foe. J Clin Tuberc Other Mycobact Dis. 2016 may 1;3:13
dc.relationStataCorp. Stata Statistical Software: Release 15. College Station, TX: StataCorp; 2017
dc.relationFrieden TR, Harold Jaffe DW, Moran JS, Leahy MA, Martinroe JC, Spriggs SR, et al. Revised Surveillance Case Definition for HIV Infection — United States, 2014. MMWR. 2014;63(3):1–13.
dc.relationRuiz L, Maya MA, Rueda ZV, López L, Vélez LA. Current characteristics of tuberculosis and human immunodeficiency virus co-infection in a cohort of hospitalized patients in Medellín, Colombia. Biomedica. 2018;38:59–67
dc.relationAbay SM, Deribe K, Reda AA, Biadgilign S, Datiko D, Assefa T, et al. The effect of early initiation of antiretroviral therapy in TB/HIV-coinfected patients: A systematic review and meta-analysis. J Int Assoc Provid AIDS Care. 2015;14(6):560–70
dc.relationSeddon JA, Tugume L, Solomons R, Prasad K, Bahr NC, Aarnoutse RE, et al. The current global situation for tuberculous meningitis: Epidemiology, diagnostics, treatment and outcomes. Vol. 4, Wellcome Open Research. F1000 Research Ltd; 2019
dc.relationCecchini D, Ambrosioni J, Brezzo C, Corti M, Rybko A, Perez M, et al. Tuberculous meningitis in HIV-infected and non-infected patients: comparison of cerebrospinal fluid findings. Vol. 13, INT J TUBERC LUNG DIS. 2009
dc.rightsAtribución-NoComercial-CompartirIgual 4.0 Internacional
dc.rightshttp://creativecommons.org/licenses/by-nc-sa/4.0/
dc.rightsinfo:eu-repo/semantics/openAccess
dc.titleCaracterización clínica de la tuberculosis pulmonar y extrapulmonar en pacientes con coinfección por VIH en una IPS especializada en Bogotá
dc.typeTrabajo de grado - Especialidad Médica


Este ítem pertenece a la siguiente institución